Hormone Resistant Prostate Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T
Conditions: Bone Metastases; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate CancerInterventions: Radiation: radiation therapy; Other: laboratory biomarker analysisSponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI); DendreonRecruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2013 Category: Research Source Type: clinical trials
Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T
Conditions: Bone Metastases; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate CancerInterventions: Radiation: radiation therapy; Other: laboratory biomarker analysisSponsors: Roswell Park Cancer Institute; National Cancer Institute (NCI); DendreonRecruiting - verified November 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2013 Category: Research Source Type: clinical trials
Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T
Conditions: Bone Metastases; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Stage IV Prostate CancerInterventions: Radiation: radiation therapy; Other: laboratory biomarker analysisSponsors: Roswell Park Cancer Institute; Roswell Park Cancer Institute; National Cancer Institute (NCI)Recruiting - verified September 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2013 Category: Research Source Type: clinical trials
